These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1591423)

  • 1. A nationwide investigation of a possible protamine drug-product defect.
    Herrera CR; Grasela TH; Walawander CA
    Ann Pharmacother; 1992 May; 26(5):643-4. PubMed ID: 1591423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists' attitudes following an awareness workshop.
    Alraie NA; Saad AA; Sabry NA; Farid SF
    J Eval Clin Pract; 2016 Jun; 22(3):349-55. PubMed ID: 26638825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.
    Kimmel SE; Sekeres MA; Berlin JA; Goldberg LR; Strom BL
    J Clin Epidemiol; 1998 Jan; 51(1):1-10. PubMed ID: 9467629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncardiogenic pulmonary edema immediately following rapid protamine administration.
    Brooks JC
    Ann Pharmacother; 1999 Sep; 33(9):927-30. PubMed ID: 10492491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
    Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of surveying the adverse drug reaction surveillance systems in a large community of hospitals.
    Herrera CR; Moss JT; Reves RR; Buffler PA
    Ann Pharmacother; 1992 Mar; 26(3):384-91. PubMed ID: 1554961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of social influences on pharmacists' intention to report adverse drug events.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
    J Am Pharm Assoc (2003); 2012; 52(5):622-9. PubMed ID: 23023842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
    Lutjen DL; Arndt KL
    AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
    Generali JA; Danish MA; Rosenbaum SE
    Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring.
    Grasela TH; Walawander CA; Kennedy DL; Jolson HM
    Am J Hosp Pharm; 1993 Sep; 50(9):1889-95. PubMed ID: 8135235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.
    Lango R; MroziĊ„ski P; Wujtewicz M; Suchorzewska J; Rogowski J; Narkiewicz M; Siebert J
    Med Sci Monit; 2000; 6(4):769-75. PubMed ID: 11208407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
    Kudoh O; Warabi K; Yamaguchi K; Ichinose M; Iizuka T; Inada E
    Masui; 2006 May; 55(5):605-10. PubMed ID: 16715917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic changes during protamine administration.
    Michaels IA; Barash PG
    Anesth Analg; 1983 Sep; 62(9):831-5. PubMed ID: 6603799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine reaction in a patient undergoing coronary artery bypass grafting.
    Hughes C; Haddock M
    CRNA; 1995 Nov; 6(4):172-6. PubMed ID: 8680346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.